Beyond traditional monitoring of kidney transplant recipients, donor derived-cell free DNA may permit early identification of graft damage.

A blood test measuring donor‑derived cell‑free DNA (dd‑cfDNA) is emerging as a sensitive tool for early detection of kidney transplant rejection, potentially reducing the need for invasive biopsies.

Despite being detectable through low-cost tests, CKD remains one of the most overlooked health conditions. Lack of awareness ...

This test is based on the RNA genetic markers forkhead box P3 (FoxP3), granzyme B (:GZMB), and perforin (PRF1). These biomarkers are licensed from the Beth Israel Deaconess Medical Center (:BIDMC) in ...

The revolutionary world of medical imaging continues to transform how healthcare professionals protect our most vital organs, and kidney ultrasounds stand at the forefront of this incredible ...

Testing for coronary heart disease before kidney transplantation is common practice, but may not be warranted for all patients, according to investigators. Routine testing for coronary heart disease ...

OBJECTIVES: Clinical practice guidelines recommend at least annual testing of estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (uACR) for patients with chronic kidney ...

Kidney dialysis can be disruptive in a patient's life. Just ask Kristal Higgins of Mississippi. She's been on dialysis for all 13 years of her daughter's life. "And my daughter understands that in ...

Renal function testing is underused to diagnose and manage lupus nephritis. Appropriate testing may help reduce disease progression and the associated worsening of outcomes. Investigators analysed ...

Dozens gathered at Highland Community Park on Saturday for the National Kidney Foundation’s annual Kidney Walk, an event ...

Although APOL1 variants are linked to kidney disease risk, the presence of the M1 genetic variant appears to reduce that risk.